ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Morosini MI, Quereda C, Gil H, Anda P, Nuñez-Murga M, Cantón R, Lopez-Vélez R, 2013. Melioidosis in traveler from Africa to Spain. Emerg Infect Dis 19: 1656–1659.
-
2.
Limmathurotsakul D, Golding N, Dance DAB, Messina JP, Pigott DM, Moyes CL, Rollim DB, Bertherat E, Day NPJ, Peacock SJ, Hay SI, 2016. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiol 1: 1–5.
-
3.
Cuadros J, Gil H, De Miguel J, Arroyo Peña Gomez-Herruz T, Lobo B, Marcos R, Anda P, 2011. Case report: melioidosis imported from west Africa to Europe. Am J Trop Med Hyg 85: 282–284.
-
4.
Borgherini G, Poubeau P, Paganin F, Picot S, Michault A, Thibault F, Berod CA, 2006. Melioidosis: and imported case from Madagascar. J Travel Med 13: 318–320.
-
5.
Issack MI, Bundhun CD, Gokhool H, 2005. Melioidosis in Mauritius. Emerg Infect Dis 11: 139–140.
-
6.
Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, Chaowagul W, Simpson AJ, Short JM, Wongsuvan G, Maharjan B, White NJ, Peacock SJ, 2005. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 55: 1029–1031.
-
7.
Clinical and Laboratory Standards Institute, 2016. MS100: Performance Standards for Antibiotic Susceptibility Testing, 26th edition. Wayne, PA: Clinical and Laboratory Standards Institute.
-
8.
Dance DAB, 1991. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 4: 52–60.
-
9.
Chan KP, Low JG, Raghuram J, Fook-Chong SM, Kurup A, 2005. Clinical characteristics and outcome of severe melioidosis requiring intensive care. Chest 128: 3674–3678.
-
10.
Viktorov DV, Zakharova IB, Podshivalova MV, Kalinkina EV, Merinova OA, Ageeva NP, Antonov VA, Merinova LK, Alekseev VV, 2008. High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 102: S103–S110.
-
11.
Sarovich DS, Garin B, De Smet B, Kaestli M, Mayo M, Vandamme P, Jacobs J, Lompo P, Tahita MC, Tinto T, Djaomalaza I, Currie BJ, Prince EP, 2016. Phylogenomic analysis reveals an Asian origin for African Burkholderia pseudomallei and further supports melioidosis endemicity in Africa. mSphere 1: e00089-15.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 720 | 646 | 8 |
| Full Text Views | 297 | 13 | 0 |
| PDF Downloads | 85 | 13 | 0 |
A Burkholderia pseudomallei Infection Imported from Eritrea to Israel
Yaniv Almog
Yaniv Almog
Internal Medicine Intensive Care Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Search for other papers by Yaniv Almog in
Current site
Google Scholar
PubMed
Search for other papers by Yaniv Almog in
Current site
Google Scholar
PubMed
Yael Yagel
Yael Yagel
Infectious Diseases Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Search for other papers by Yael Yagel in
Current site
Google Scholar
PubMed
Search for other papers by Yael Yagel in
Current site
Google Scholar
PubMed
Yuval Geffen
Yuval Geffen
Clinical Microbiology Laboratory, Rambam Medical Center, Haifa, Israel.
Search for other papers by Yuval Geffen in
Current site
Google Scholar
PubMed
Search for other papers by Yuval Geffen in
Current site
Google Scholar
PubMed
Pablo Yagupsky
Pablo Yagupsky
Clinical Microbiology Laboratory, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Search for other papers by Pablo Yagupsky in
Current site
Google Scholar
PubMed
Search for other papers by Pablo Yagupsky in
Current site
Google Scholar
PubMed
Although it has been predicted that melioidosis is probably endemic in the Horn of Africa, no confirmed cases have ever been detected in the region. We have recently isolated Burkholderia pseudomallei from an Eritrean patient in Israel. The isolate was assigned a novel multilocus sequence type (ST-1479). The observation has important epidemiological implications in an era of massive human migration.
Author Notes
Authors' addresses: Yaniv Almog, Intensive Care Unit, Soroka University Medical Center, Beer-Sheva, Israel, E-mail: yaniva@clalit.org.il. Yael Yagel, Infectious Diseases Unit, Soroka University Medical Center, Beer-Sheva, Israel, E-mail: grushka@gmail.com. Yuval Geffen, Clinical Microbiology Laboratory, Rambam Medical Center, Haifa, Israel, E-mail: y_geffen@rambam.health.gov.il. Pablo Yagupsky, Clinical Microbiology Laboratory, Soroka University Medical Center, Beer-Sheva, Israel, E-mail: pyagupsky@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Morosini MI, Quereda C, Gil H, Anda P, Nuñez-Murga M, Cantón R, Lopez-Vélez R, 2013. Melioidosis in traveler from Africa to Spain. Emerg Infect Dis 19: 1656–1659.
-
2.
Limmathurotsakul D, Golding N, Dance DAB, Messina JP, Pigott DM, Moyes CL, Rollim DB, Bertherat E, Day NPJ, Peacock SJ, Hay SI, 2016. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiol 1: 1–5.
-
3.
Cuadros J, Gil H, De Miguel J, Arroyo Peña Gomez-Herruz T, Lobo B, Marcos R, Anda P, 2011. Case report: melioidosis imported from west Africa to Europe. Am J Trop Med Hyg 85: 282–284.
-
4.
Borgherini G, Poubeau P, Paganin F, Picot S, Michault A, Thibault F, Berod CA, 2006. Melioidosis: and imported case from Madagascar. J Travel Med 13: 318–320.
-
5.
Issack MI, Bundhun CD, Gokhool H, 2005. Melioidosis in Mauritius. Emerg Infect Dis 11: 139–140.
-
6.
Wuthiekanun V, Cheng AC, Chierakul W, Amornchai P, Limmathurotsakul D, Chaowagul W, Simpson AJ, Short JM, Wongsuvan G, Maharjan B, White NJ, Peacock SJ, 2005. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 55: 1029–1031.
-
7.
Clinical and Laboratory Standards Institute, 2016. MS100: Performance Standards for Antibiotic Susceptibility Testing, 26th edition. Wayne, PA: Clinical and Laboratory Standards Institute.
-
8.
Dance DAB, 1991. Melioidosis: the tip of the iceberg? Clin Microbiol Rev 4: 52–60.
-
9.
Chan KP, Low JG, Raghuram J, Fook-Chong SM, Kurup A, 2005. Clinical characteristics and outcome of severe melioidosis requiring intensive care. Chest 128: 3674–3678.
-
10.
Viktorov DV, Zakharova IB, Podshivalova MV, Kalinkina EV, Merinova OA, Ageeva NP, Antonov VA, Merinova LK, Alekseev VV, 2008. High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 102: S103–S110.
-
11.
Sarovich DS, Garin B, De Smet B, Kaestli M, Mayo M, Vandamme P, Jacobs J, Lompo P, Tahita MC, Tinto T, Djaomalaza I, Currie BJ, Prince EP, 2016. Phylogenomic analysis reveals an Asian origin for African Burkholderia pseudomallei and further supports melioidosis endemicity in Africa. mSphere 1: e00089-15.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 720 | 646 | 8 |
| Full Text Views | 297 | 13 | 0 |
| PDF Downloads | 85 | 13 | 0 |